The Effect of a Low Glycemic Index Diet on Blood Sugar Control in Pregnant Women at Risk for Gestational Diabetes

March 11, 2013 updated by: Thomas Wolever, University of Toronto
Gestational diabetes mellitus (GDM) is a condition in which high blood sugar levels occur during pregnancy. GDM increases the risk of medical complications during pregnancy which may harm the mother and her baby. Since treating GDM to reduce blood sugar reduces the risk of harm, all pregnant women are screened for GDM using a glucose challenge test (GCT). We think that a diet containing low glycemic index foods could help keep blood sugar levels normal during pregnancy and therefore prevent GDM. Thus, the purpose of this study is to see if a diet containing low glycemic index foods will reduced blood sugar after the GCT and reduce the prevalence of GDM in women at high risk for the development of GDM.

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

103

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Ontario
      • Toronto, Ontario, Canada, M5G 1X5
        • Mt Sinai Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Attending Mt. Sinai Maternal Fetal Medicine Unit
  • Any ONE of: body mass index >=25 kg/m^2
  • OR age >=35 years
  • OR high risk ethnicity (Asian, South Asian, Hispanic, African, Aboriginal)

Exclusion Criteria:

  • Have pre-existing diabetes (type 1 or type 2) before becoming pregnant
  • Acute or chronic illness which may affect carbohydrate metabolism
  • Language/literacy barriers which cannot be overcome via available resources
  • >16 weeks gestation

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Placebo Comparator: High fiber
High fiber carbohydrate foods with a high / medium glycemic index. Whole wheat bread and/or brown rice are provided to subjects if they wish. Subjects are provided with a list of other recommended carbohydrate foods.
Group nutrition classes supplemented by handouts and provision of key study foods.
Active Comparator: Low GI
Carbohydrate foods with a low glycemic index. Low GI rice and whole grain bread provided to subjects if they wish. Subjects are provided with a list of recommended foods.
Group nutrition classes supplemented by handouts and provision of key study foods.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Serum glucose concentration 1hr after glucose challenge test
Time Frame: 26 weeks gestation
26 weeks gestation

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
GCT outcome
Time Frame: 26 weeks gestation
ie. normal, borderline, abnormal
26 weeks gestation
GDM outcome
Time Frame: 26 weeks gestation
Presence or absence of gestational diabetes
26 weeks gestation
Maternal weight
Time Frame: At EACH of the following times: 12, 16, 20, 24, 28, 32, 36 and 40 weeks gestation
At EACH of the following times: 12, 16, 20, 24, 28, 32, 36 and 40 weeks gestation
Mode of delivery
Time Frame: At time of birth of baby
Normal or cesarean section
At time of birth of baby
Presence of birth trauma
Time Frame: At time of birth of baby
At time of birth of baby
Weight of baby
Time Frame: At time of birth of baby
At time of birth of baby
Presence of macrosomia
Time Frame: At time of birth of baby
At time of birth of baby
presence of large for gestational age baby
Time Frame: At time of birth of baby
At time of birth of baby
Presence of small for gestational age baby
Time Frame: At time of birth of baby
At time of birth of baby
food frequency questionnaire
Time Frame: at 12 weeks and 26 weeks gestation
at 12 weeks and 26 weeks gestation
Acceptability of study foods
Time Frame: 26 weeks gestation
26 weeks gestation

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Thomas MS Wolever, BM, BCh, PhD, University of Toronto

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

March 1, 2010

Primary Completion (Actual)

June 1, 2011

Study Completion (Actual)

December 1, 2011

Study Registration Dates

First Submitted

April 9, 2010

First Submitted That Met QC Criteria

April 15, 2010

First Posted (Estimate)

April 16, 2010

Study Record Updates

Last Update Posted (Estimate)

March 12, 2013

Last Update Submitted That Met QC Criteria

March 11, 2013

Last Verified

March 1, 2013

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Diabetes, Gestational

Clinical Trials on Nutrition education

Subscribe